FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to oncology, and can be used for treating an individual suffering HER2-positive breast cancer. That is ensured by introducing a selective androgen receptor modulator (SARM) into the subject.
EFFECT: invention provides treating a HER2-positive breast cancer in a subject.
5 cl, 14 dwg, 4 tbl, 17 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATMENT OF ANDROGEN RECEPTOR (AR)-POSITIVE FORMS OF BREAST CANCER USING SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARM) | 2013 |
|
RU2648959C2 |
COMPOSITIONS AND METHODS OF TREATING ANDROGEN-RECEPTOR-POSITIVE CANCER | 2020 |
|
RU2817802C2 |
SELECTIVE ANDROGEN RECEPTOR DESTROYING AGENTS (SARD) AND METHODS OF USING THEREOF | 2016 |
|
RU2724103C2 |
ANDROGEN RECEPTOR SELECTIVE DESTROYING (SARD) LIGANDS AND METHODS OF THEIR USE | 2017 |
|
RU2795431C2 |
SELECTIVE ANDROGEN RECEPTOR DESTROYING (SARD) LIGANDS AND METHODS OF USING THEM | 2016 |
|
RU2689988C2 |
METHODS OF TREATING AR+ BREAST CANCER | 2017 |
|
RU2769527C2 |
BENZOTHIOPHENE SELECTIVE ESTROGEN RECEPTOR BLOCKERS | 2016 |
|
RU2747802C2 |
METHODS OF TREATING UROLOGICAL DISORDERS USING SELECTIVE ANDROGEN RECEPTOR MODULATORS | 2015 |
|
RU2691652C2 |
MODULATION OF ANDROGEN RECEPTOR EXPRESSION | 2013 |
|
RU2670486C9 |
NONSTEROID MODULATORS OF ANDROGEN RECEPTOR, METHOD OF PRODUCTION, PHARMECEUTICAL COMPOSITION THEREOF AND USE | 2006 |
|
RU2378250C2 |
Authors
Dates
2020-03-26—Published
2013-03-07—Filed